hederagenin has been researched along with Cancer of Lung in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Duan, H; Han, L; Hsu, P; Lee, KH; Liu, W; Morris-Natschke, SL; Tong, X; Yang, S | 1 |
Chen, Z; Cheng, YY; Duan, HQ; Goto, M; Huang, KY; Lee, KH; Ling, Y; Liu, YL; Morris-Natschke, SL; Tong, XH; Yang, PC; Yang, SL | 1 |
Baek, SJ; Cha, S; Kim, A; Kim, NS; Lee, H; Park, M; Park, SM; Yi, JM | 1 |
Chan, MT; Chen, B; Du, B; Gu, J; Ho, IH; Liu, Q; Liu, X; Tan, Y; Wang, K; Wei, X; Wu, WK; Xiao, J; Yin, T; Zhan, Y; Zhang, L; Zhang, W | 1 |
4 other study(ies) available for hederagenin and Cancer of Lung
Article | Year |
---|---|
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cytotoxins; Erythrocytes; G1 Phase; Hemolysis; Humans; KB Cells; Lung Neoplasms; MCF-7 Cells; Rabbits; Saponins; Structure-Activity Relationship | 2018 |
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Design; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Nitric Oxide; Nitric Oxide Donors; Oleanolic Acid; Protein Kinase Inhibitors | 2019 |
Identification of a novel anticancer mechanism of Paeoniae Radix extracts based on systematic transcriptome analysis.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Aurora Kinase B; Gene Expression Profiling; Humans; Lung Neoplasms; Oleanolic Acid; Paeonia; Plant Extracts; Plant Roots | 2022 |
Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Proliferation; Cisplatin; Humans; Lung Neoplasms; Lysosomes; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Oleanolic Acid; Paclitaxel; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2020 |